







To find out why GuruFocus thinks data on insider trade are interesting, read
| Symbol | Company | Insider | Position | Date | Buy/Sell | Shares | Trade Price ($) | Cost ($1000) | Price Change Since Trade (%) |
Yield (%) | P/E | Market Cap ($M) | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | OREX | Orexigen Therap... | Hagan Joseph P | Chief Business Officer | 2013-05-28 | Sell | 28,000 | $7 | 196 | -8.86 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | Klassen Preston | SVP, Head Global Development | 2013-05-28 | Sell | 28,771 | $7.21 | 207.4 | -11.51 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | Booth Mark D | Chief Commercial Officer | 2013-03-11 | Sell | 27,685 | $6.67 | 184.7 | -4.35 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | Booth Mark D | Chief Commercial Officer | 2013-01-15 | Sell | 22,315 | $6.67 | 148.8 | -4.35 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | NARACHI MICHAEL | President and CEO (Click for the stocks that their CEOs have bought) | 2012-07-17 | Sell | 150,000 | $7.66 | 1149 | -16.71 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | Turner Heather D | SVP, Gen. Counsel & Secretary | 2012-07-17 | Sell | 82,433 | $7.68 | 633.1 | -16.93 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | NARACHI MICHAEL | President and CEO | 2012-07-13 | Sell | 150,000 | $6.7 | 1005 | -4.78 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | Hagan Joseph P | Chief Business Officer | 2012-07-13 | Sell | 30,000 | $6.77 | 203.1 | -5.76 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | NARACHI MICHAEL | President and CEO | 2012-06-29 | Sell | 225,000 | $5.89 | 1325.3 | 8.32 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | Booth Mark D | Chief Commercial Officer | 2012-06-28 | Sell | 103,309 | $5.66 | 584.7 | 12.72 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | Hagan Joseph P | Chief Business Officer | 2012-06-29 | Sell | 108,000 | $5.53 | 597.2 | 15.37 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | DOVEY BRIAN H | Director, 10% Owner | 2011-12-22 | Buy | 469,147 | $1.45 | 680.3 | 340 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | Halak Brian K | 10% Owner | 2011-12-22 | Buy | 469,147 | $1.45 | 680.3 | 340 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | TREU JESSE I | 10% Owner | 2011-12-22 | Buy | 469,147 | $1.45 | 680.3 | 340 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | SCHOEMAKER KATHLEEN K | 10% Owner | 2011-12-22 | Buy | 469,147 | $1.45 | 680.3 | 340 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | VITULLO NICOLE | 10% Owner | 2011-12-22 | Buy | 469,147 | $1.45 | 680.3 | 340 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | BLAIR JAMES C | 10% Owner | 2011-12-22 | Buy | 469,147 | $1.45 | 680.3 | 340 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | DOMAIN PARTERS VII L P | 10% Owner | 2011-12-22 | Buy | 461,265 | $1.45 | 668.8 | 340 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | DP VII ASSOCIATES LP | 10% Owner | 2011-12-22 | Buy | 7,882 | $1.45 | 11.4 | 340 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | POWELL MICHAEL | Director | 2010-12-23 | Sell | 825,000 | $8.29 | 6839.3 | -23.04 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | POWELL MICHAEL | Director | 2010-12-20 | Sell | 456,254 | $8.58 | 3914.7 | -25.64 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | BREEN DORON | 2010-07-12 | Sell | 20,000 | $4.15 | 83 | 53.73 | 0.00 | 0.00 | 614.7 | ||
![]() | OREX | Orexigen Therap... | Arkin Moshe | 2010-07-15 | Sell | 105,000 | $5.64 | 592.2 | 13.12 | 0.00 | 0.00 | 614.7 | ||
![]() | OREX | Orexigen Therap... | POWELL MICHAEL | Director | 2010-03-19 | Sell | 700,000 | $6.13 | 4291 | 4.08 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | COOPER GRAHAM K | CFO and Treasurer | 2009-12-21 | Sell | 82,500 | $8.22 | 678.2 | -22.38 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | COOPER GRAHAM K | CFO and Treasurer | 2009-12-21 | Sell | 17,500 | $8.39 | 146.8 | -23.96 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | SCHOEMAKER KATHLEEN K | 10% Owner | 2009-12-18 | Buy | 138,100 | $7.54 | 1041.3 | -15.38 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | DOMAIN PARTERS VII L P | 10% Owner | 2009-12-18 | Buy | 135,784 | $7.54 | 1023.8 | -15.38 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | DP VII ASSOCIATES LP | 10% Owner | 2009-12-18 | Buy | 2,316 | $7.54 | 17.5 | -15.38 | 0.00 | 0.00 | 614.7 | |
![]() | OREX | Orexigen Therap... | BLAIR JAMES C | 10% Owner | 2009-12-18 | Buy | 138,100 | $7.54 | 1041.3 | -15.38 | 0.00 | 0.00 | 614.7 |
| Guru Name | Portfolio Date* | Current Shares (?) | % of Total Assets (?) | Change from Last Holdings (?) | |
|---|---|---|---|---|---|
| John Burbank | 2013-03-31 | 750,000 | 0.19% | ||
| RS Investment Management | 2013-03-31 | 1,453,900 | 0.07% | +14.64% | |
| Steven Cohen | 2013-03-31 | 9,700 | 0% | -99.49% | |
Most recent portfolio changes are included for Premium Members only!
| |||||
Add Notes, Comments or Ask Questions
Comments